Drug details:
Molecular formula: C₂₆H₂₁N₃O₅S

Standard name: [2-[2-(methylcarbamoyl)-2,3-dihydro-1,4-benzoxazin-4-yl]-2-oxoethyl] 2-thiophen-2-ylquinoline-4-carboxylate

Curated SMILES: CNC(=O)C1CN(C(=O)COC(=O)C2=C3C=CC=CC3=NC(C3=CC=CS3)=C2)C2=C(C=CC=C2)O1

Evidence for compound's anti-virulence activity:

Shigella
Related VF: TTSS (Type III secretion system)
Target: Spa47
Drug effect: Inhibits T3SS ATPase.
Max phase: Preclinical (in vitro)
Publication:
Case HB, et al., 2018. Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors. Biochemistry 57(50):6906-6916.